Nosocomial Pneumonia Epidemiology Common hospital-acquired infection Occurs at a rate of approximately 5-10 cases per 1000 hospital admissions Incidence.

Slides:



Advertisements
Similar presentations
Yong Lee ICU Registrar John Hunter Hospital
Advertisements

Prevention of Ventilator Associated Pneumonia
VENTILATOR – ACQUIRED PNEUMONIA Professor of Respiratory Medicine
Ventilator Care Bundle
Nikola Bla ž evi ć Mentor: A. Ž mega č Horvat. - inflammation of the lungs caused by infection - many different causes: bacteria, viruses, fungi, idiopathic.
Nosocomial Pneumonia Eliane Haron,M.D.. Nosocomial Pneumonia Epidemiology Common hospital-acquired infection Occurs at a rate of approximately 5-10 cases.
Pneumonia Why do we need to know about it? Long recognized as a major cause of death, Pneumonia has been studied intensively since late 1800s. Despite.
Ventilator Associated Pneumonia (VAP)
*VAP % of all nosocomial infections in ICU. *VAP % of all mechanical ventilated patients. *VAP % morbidity and mortality.
Health Care Associated Pneumonia Respiratory Block
Chapter 22 Pulmonary Infections Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc.
Executive Summary(4) A shorter duration of ABx therapy (7 to 8 days): recommended for - uncomplicated HAP, VAP, or HCAP - with initially appropriate therapy.
Ventilator-Associated Pneumonia. Introduction Definition 48 hours after intubation mechanically ventilated No clinical evidence of pneumonia prior to.
#1005 Hospital & Community Acquired Pneumonias October 19 to October 22 Stephen Hoffmann, MD Clinical Instructor of Internal Medicine Division of Pulmonary.
Lower Respiratory Tract Infection. Pneumonia Common with high morbidity and mortality rates. Acute respiratory infection with focal chest signs and radiographic.
Journal Club. Background to the paper Pneumonia is THE MOST COMMON nosocomial infection in ICU patients 12 to 18 cases per 1000 ventilator days Oropharyngeal.
Safer Healthcare Now! Ventilator Acquired Pneumonia Presented by Amanda Thompson, Safer Healthcare Now Facilitator April 12, 2007.
Biofilms on Medical Devices
Objectives Upon completion of the lecture, students should be able to:  Define middle ear infection  Know the classification of otitis media (OM). 
Prevention of Nosocomial Infections
1 Telligen Quality Innovation Network- Quality Improvement Organization Ventilator Associated Events –VAE June 26, 2015 This material was prepared by Telligen,
GENERAL TEMPLATE FOR A 48”X36” POSTER Name(s) of Author(s) 1 ; Name(s) of Author(s) 2 ; Name(s) of Author(s) 3 1. Name of Institution; 2. Name on Institution;
SPM 200 Skills Lab 6 Nasogastric Tube (NGT) / Oral and Nasal Airways / O2 Delivery Devices Daryl P. Lofaso, MEd, RRT Clinical Skills Lab Coordinator.
Health Care Associated Pneumonia Respiratory Block BY PROF.A.M.KAMBAL and PROF.HANAN HABIB Department of Pathology, KSU.
Infections in the intensive care unit Wanida Paoin Thammasat University.
Case # 31 M.C., a 60y/o male, has already been experiencing nausea, vomiting & diarrhea aside from having developed PNEUMONIA while in the hospital. Lab.
Nosocomial Pneumonia Hospital Acquired, Ventilator Associated, Healthcare Associated Pneumonia.
PRESENTER: HALIMATUL NADIA M HASHIM SUPERVISOR: DR NIK AZMAN NIK ADIB.
Chapter 22 Pulmonary Infections. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Objectives  State the incidence.
SPM 100 Clinical Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT.
Part I BACKGROUND VENTILATOR ASSOCIATED PNEUMONIA.
Pneumonia Dr. Abdul-Monim Batiha Assistant Professor Critical Care Nursing Philadelphia university.
ความหมาย As Pneumonia in patient who have been on mechanical ventilation for greater than 48 hrs.
Life-Threatening Infections: Diagnosis and Antimicrobial Therapy Selection.
SPM 100 Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT Clinical Skills Lab Coordinator.
Andriy Lepyavko, MD, PhD Department of Internal Medicine № 2.
Pneumonia Egan’s Chapter 22. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Introduction Infection involving the.
Hospital Acquired Pneumonia(HAP): is defined as a pneumonia which occurs after 48 hours of admission to hospital. Hospital Acquired Pneumonia(HAP): is.
Ventilator Associated Pneumonia (VAP)
Mini BAL v/s Bronchoscopic BAL PROF. PRADYUT WAGHRAY MD (CHEST), DTCD, FCCP (USA),D.SC(PULM. MEDICINE) HEAD OF DEPT. OF PULMONARY MEDICINE S.V.S MEDICAL.
Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals 2014 Update Dr Neda Alijani.
Ventilator-associated pneumonia (VAP) Ventilator-associated pneumonia (VAP) is defined as nosocomial pneumonia in a patient on mechanical ventilatory support.
ax0thor_lecthorax1.jpg RUL RML RLL LUL LLL Lingula.
Nosocomial infection Hospital acquired infections.
MICROBIOLOGICAL EPIDEMIOLOGY OF RESPIRATORY SPECIMENS IN ICU PATIENTS Dr Farooq Cheema, Dr Waseem Tariq, Dr Raja Ishtiaq, Dr Tabassum Qureshi, Dr Vincent.
Pneumonia. Definition Pneumonia is an inflammation of the lung parenchyma that is caused by a microbial agent. “Pneumonitis” is a more general term that.
Hospital Acquired Pneumonia (HAP) By Professor Adel Khattab Prof. of Pulmonary Medicine Ain Shams University
ICU Nosocomial Pneumonia
Nosocomial infection Hospital acquired infections.
Ventilator-Associated Pneumonia (VAP) An Overview for RC Students Special thanks to: Donald Dumford Donald Dumford Beth Israel Deaconess Medical Center.
Ventilator Associated Pneumonia. Ventilator-associated pneumonia (VAP) is a form of hospital-associated pneumonia (HAP) which develops in mechanically.
Is a Strategy Based on Routine Endotracheal Cultures the Best Way to Prescribe Antibiotics in Ventilator-Associated Pneumonia? CHEST 2013; 144(1):63-71.
Depart. Of Pulmonology and Critical Care Medicine R4 백승숙.
Community Acquired Pneumonia. Definitions Community acquired pneumonia (CAP) – Infection of the lung parenchyma in a person who is not hospitalized or.
Ventilator-Associated Pneumonia
Comparison between pathogen directed antibiotic treatment and empiri cal broad spectrum antibiotic treatment in patients with community acquired pneumonia.
Hospital-Acquired Pneumonia
Health Care Associated Pneumonia Respiratory Block
Health Care Associated Pneumonia
Hospital acquired infections
Health Care Associated Pneumonia Respiratory Block
Ventilator-Associated Tracheobronchitis
A Quick Review: Preventing Ventilator-Associated Pneumonia (VAP)
PHARMACOTHERAPY III PHCY 510
Sputum Culture بسم الله الرحمن الرحيم
Surveillance of Post-operative pneumonia
Health Care Associated Pneumonia
Health Care Associated Pneumonia Respiratory Block
Community Acquired Pneumonia
Presentation transcript:

Nosocomial Pneumonia Epidemiology Common hospital-acquired infection Occurs at a rate of approximately 5-10 cases per 1000 hospital admissions Incidence increases by 6-20 fold in patients being ventilated mechanically. One study suggested that the risk for developing VAP increases 1% per day Another study suggested, highest risk occur in the first 5 days after intubation

Nosocomial Pneumonia

Epidemiology Nosocomial pneumonia is the leading cause of death due to hospital acquired infections Associated with substantial morbidity Has an associated crude mortality of 30-50% Hospital stay increases by 7-9 days per patient Estimated cost > 1 billion dollars/year

Nosocomial Pneumonia Hence, the importance of focusing on: Accurate diagnosis Appropriate treatment Preventive measures

Nosocomial Pneumonia Pathogenesis Risk factors Etiologic agents Differential diagnosis Treatment Prevention

Pathogenesis

Nosocomial Pneumonia Microaspiration may occur in up to 45% of healthy volunteers during sleep Oropharynx of hospitalized patients is colonized with GNR in 35-75% of patients depending on the severity and type of underlying illness Multiple factors are associated with higher risk of colonization with pathogenic bacteria and higher risk of aspiration

Nosocomial Pneumonia Pathogenesis Invasion of the lower respiratory tract by: Aspiration of oropharyngeal/GI organisms Inhalation of aerosols containing bacteria Hematogenous spread

Colonization Aspiration HAP MRSA*

Risk Factors

Nosocomial Pneumonia Risk Factors Host Factors Extremes of age, severe acute or chronic illnesses, immunosupression, coma, alcoholism, malnutrition, COPD, DM Factors that enhance colonization of the oropharynx and stomach by pathogenic microorganisms admission to an ICU, administration of antibiotics, chronic lung disease, endotracheal intubation, etc.

Nosocomial Pneumonia Risk Factors Conditions favoring aspiration or reflux Supine position, depressed consciousness, endotracheal intubation, insertion of nasogastric tube Mechanical ventilation Impaired mucociliary function, injury of mucosa favoring bacterial binding, pooling of secretions in the subglottic area, potential exposure to contaminated respiratory equipment and contact with contaminated or colonized hands of HCWs Factors that impede adequate pulmonary toilet Surgical procedures that involve the head and neck, being immobilized as a result of trauma or illness, sedation etc.

Etiologic Agents

Nosocomial Pneumonia Etiologic Agents S.aureus Enterobacteriaceae P.aeruginosa Acinetobacter sp. Polymicrobial Anaerobic bacteria Legionella sp. Aspergillus sp. Viral

Diagnosis

Nosocomial Pneumonia Diagnosis Not necessarily easy to accurately diagnose HAP Criteria frequently include: Clinical fever ; cough with purulent sputum, Radiographic new or progressive infiltrates on CXR, Laboratorial leukocytosis or leukopenia Microbiologic Suggestive gram stain and positive cultures of sputum, tracheal aspirate, BAL, bronchial brushing, pleural fluid or blood Quantitative cultures

Nosocomial Pneumonia Problems All above criteria fairly sensitive, but very non- specific, particularly in mechanically ventilated patients Other criteria/problems include Positive cultures of blood and pleural fluid plus clinical findings (specific but poor sensitivity) Rapid cavitation of pulmonary infiltrate absent Tb or cancer (rare) Histopathologic examination of lung tissue (invasive)

Nosocomial pneumonia Bronchoscopically Directed Techniques for diagnosis of VAP and Quantitative cultures Bronchoscopy with BAL/bronchial brushings (10,000 to 100,000 CFU/ml and less than 1% of squamous cells) Protected specimen brush method (>10³ CFU/ml) Protected BAL with a balloon tipped catheter (>5% of neutrophils or macrophages with intracellular organisms on a Wright-Giemsa stain)

Nosocomial pneumonia Multiple studies looked into the accuracy of quantitative culture and microscopic examination of LRT secretions as compared to histopathologic examination and tissue cultures (either lung biopsy or immediate post mortem obtained samples) Several trials conclude that use of FOB techniques and quantitative cultures are more accurate At least 4 studies concluded that bronchoscopically directed techniques were not more accurate for diagnosis of VAP than clinical and X-ray criteria, combined with cultures of tracheal aspirate Therefore no gold standard criteria exist

Nosocomial Pneumonia Differential diagnosis ARDS Pulmonary edema Pulmonary embolism Atelectasis Alveolar hemorrhage Lung contusion

Treatment

Nosocomial Pneumonia Antimicrobial Treatment Broad spectrum penicillins 3 rd and 4 th generation cephalosporins Carbapenems Quinolones Aminoglycosides Vancomycin Linezolid

Inadequate Antibiotic Therapy Antibiotic Resistance

Nosocomial Pneumonia Duration of antimicrobial treatment Optimal duration of treatment has not been established Most experts recommend days of treatment Recent data support shorter treatment regimens (8 days)

Prevention

Nosocomial Pneumonia Preventive Measures Incentive spirometry Promote early ambulation Avoid CNS depressants Decrease duration of immunosupression Infection control measures Educate and train personnel

Nosocomial Pneumonia Preventive Measures Avoid prolonged nasal intubation Suction secretions Semi-recumbent position( 30-45°head elevation) Do not change ventilator circuits routinely more often than every 48 hours Drain and discard tubing condensate Use sterile water for respiratory humidifying devices Subglottic secretions drainage

Craven, et al. Chest. 1995;108:s1-s16.

Nosocomial Pneumonia Preventive Measures Remove NGT when no longer needed Avoid gastric overdistention Stress ulcer prophylaxis: sulcrafate; antacids; H2 receptor antagonists Acidification of enteral feedings Prophylactic antibiotics Inhaled antibiotics Selective digestive decontamination Chlorexidine oral rinses Vaccines ( Influenza; Strep.pneumoniae)